{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T17:44:13Z","timestamp":1776793453100,"version":"3.51.2"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T00:00:00Z","timestamp":1746489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Hochschule Hannover (MHH)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>Cerebrospinal fluid (CSF) rhinorrhea is a rare complication after dopamine agonist treatment of macroprolactinomas. Up to 90% need surgical repair, however, there are controversial opinions on the necessity of tumor resection upon this occasion. Here we present our long-term follow-up experience in patients who underwent surgical repair of the CSF leak or observation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We report a series of three patients who presented with cabergoline-induced CSF rhinorrhea with long-term follow-up up to 170 months. Two patients underwent endoscopic transnasal-transsphenoidal surgical repair of CSF rhinorrhea by fat graft and fibrin glue without tumor removal. In another patient, CSF rhinorrhea resolved spontaneously after two weeks without recurrence.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>All three patients had no recurrence of CSF rhinorrhea during long-term follow-up up to 170 months. One patient with surgical CSF leak repair was asymptomatic with continued medication at long-term follow-up of 116 months. Tumor progression occurred 21 months after CSF leakage repair in another patient after cessation of dopamine agonist treatment and necessitated tumor debulking. The patient with continued medication without surgery had no recurrence of CSF rhinorrhea on long-term follow-up of 170 months.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The optimal management of CSF fistulae due to tumor shrinkage of macroprolactinomas after dopamine agonist therapy remains to be defined. Exceptionally, medication-induced CSF fistulae in response to tumor shrinkage may close spontaneously without recurrence. If persistent, transnasal-transsphenoidal closure of CSF fistulae represents an efficient treatment and dopamine agonist treatment may be continued. Thus, we recommend early surgical repair.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00423-025-03722-8","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T06:11:10Z","timestamp":1746511870000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Cabergoline-induced cerebrospinal fluid fistulae in macroprolactinomas"],"prefix":"10.1007","volume":"410","author":[{"given":"Elvis J.","family":"Hermann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Hertz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Terkamp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M.","family":"Kinfe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Stolle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Leitolf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudolf","family":"Fahlbusch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim K.","family":"Krauss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,6]]},"reference":[{"key":"3722_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1365-2265.2006.02562.x","volume":"65","author":"FF Casanueva","year":"2006","unstructured":"Casanueva FF, Molitch ME, Schlechte JA, Abs R, Bonert V, Bronstein MD, Brue T, Cappabianca P, Colao A, Fahlbusch R, Fideleff H, Hadani M, Kelly P, Kleinberg D, Laws E, Marek J, Scanlon M, Sobrinho LG, Wass JAH, Giustina A (2006) Guidelines of the pituitary society for the diagnosis and management of prolactinomas. Clin Endocrinolog (Oxf) 65:265\u2013273. https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02562.x","journal-title":"Clin Endocrinolog (Oxf)"},{"key":"3722_CR2","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1210\/er.2005-9998","volume":"27","author":"MP Gillam","year":"2006","unstructured":"Gillam MP, Molitch ME, Lambardi G, Colao A (2006) Advances in the treatment of prolactinomas. Endocr Rev 27:485\u2013534. https:\/\/doi.org\/10.1210\/er.2005-9998","journal-title":"Endocr Rev"},{"issue":"1","key":"3722_CR3","doi-asserted-by":"publisher","first-page":"46128","DOI":"10.1007\/s10143-023-02033-0","volume":"46","author":"M Ottenhausen","year":"2023","unstructured":"Ottenhausen M, Conrad J, Wolters LM, Ringel F (2023) Surgery as first-line treatment for prolactinoma? Discussion of the literature and results of a consecutive series of surgically treated patients. Neurosurg Rev 46(1):46128. https:\/\/doi.org\/10.1007\/s10143-023-02033-0","journal-title":"Neurosurg Rev"},{"issue":"3","key":"3722_CR4","doi-asserted-by":"publisher","first-page":"712","DOI":"10.3171\/2023.6.JNS23570","volume":"140","author":"RC Osorio","year":"2023","unstructured":"Osorio RC, Haddad AF, Hart DM, Goldrich N, Badani A, Kabir AS, Juncker R, Oh JY, Carrete L, Peeran Z, Chalif EJ, Zheng AC, Braunstein S, Theodosopoulos PV, El-Sayed IH, Gurrola J, Kunwar S, Blevins LS, Aghi MK (2023) Socioeconomic differences between medically and surgically treated prolactinomas: a retrospective review of 598 patients. J Neurosurg 140(3):712\u2013723. https:\/\/doi.org\/10.3171\/2023.6.JNS23570","journal-title":"J Neurosurg"},{"key":"3722_CR5","doi-asserted-by":"publisher","first-page":"108079","DOI":"10.1016\/j.clineuro.2023.108079","volume":"236","author":"MC Findlay","year":"2014","unstructured":"Findlay MC, Sabahi M, Azab M, Drexler R, Rotermund R, Ricklefs FL, Flitsch J, Smith TR, Kilgallon JL, Honegger J, Nasi-Kordhishti I, Gardner PA, Gersey ZC, Abdallah HM, Jane JA, Knappe UJ, Uksul N, Schroder HWS, E\u00f6rd\u00f6gh M, Losa M, Mortini P, Gerlach R, Antunes ACM, Couldwell WT, Budohoski KP, Rennert RC, Karsy M (2014) The role of surgical management for prolactin-secreting tumors in the era of dopaminergic agonists: an international multicenter report. Clin Neurol Neurosurg 236:108079. https:\/\/doi.org\/10.1016\/j.clineuro.2023.108079","journal-title":"Clin Neurol Neurosurg"},{"issue":"6","key":"3722_CR6","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s11102-021-01168-x","volume":"24","author":"JY Park","year":"2021","unstructured":"Park JY, Choi W, Hong AR, Yoon JH, Kim HK, Jang WY, Jung S, Kang HC (2021) Surgery is a safe, effective first-line treatment modality for noninvasive prolactinomas. Pituitary 24(6):955\u2013963. https:\/\/doi.org\/10.1007\/s11102-021-01168-x","journal-title":"Pituitary"},{"issue":"3","key":"3722_CR7","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1210\/clinem\/dgz144","volume":"105","author":"AH Zamanipoor Najafabadi","year":"2020","unstructured":"Zamanipoor Najafabadi AH, Zandbergen IM, de Vries F, Broersen LHA, van den Akker-van Marle ME, Pereira AM, Peul WC, Dekkers OM, van Furth WR, Biermasz NR (2020) Surgery as a viable alternative first-line treatment for prolactinoma patients. A systematic review and meta-analysis. J Clin Endocrinol Metab 105(3):e32\u201341. https:\/\/doi.org\/10.1210\/clinem\/dgz144","journal-title":"J Clin Endocrinol Metab"},{"key":"3722_CR8","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1046\/j.1365-2265.1997.1300952.x","volume":"46","author":"CI Ferrari","year":"1997","unstructured":"Ferrari CI, Abs R, Bevan JS, Brabant G, Ciccarelli E, Motta T, Mucci M, Muratori M, Musatti L, Verbessem G, Scanlon MF (1997) Treatment of macroprolactinoma with Cabergoline: a study of 85 patients. Clin Endocrinol (Oxf) 46:409\u2013413. https:\/\/doi.org\/10.1046\/j.1365-2265.1997.1300952.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"3722_CR9","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1210\/jc.2010-1692","volume":"96","author":"S Melmed","year":"2011","unstructured":"Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, Wass JAH (2011) Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 96:273\u2013288. https:\/\/doi.org\/10.1210\/jc.2010-1692","journal-title":"J Clin Endocrinol Metab"},{"key":"3722_CR10","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1210\/edrv-13-2-220","volume":"13","author":"JS Bevan","year":"1992","unstructured":"Bevan JS, Webster J, Burke CW, Scanlon MF (1992) Dopamine agonists and pituitary tumor shrinkage. Endocr Rev 13:220\u2013240. https:\/\/doi.org\/10.1210\/edrv-13-2-220","journal-title":"Endocr Rev"},{"key":"3722_CR11","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1046\/j.1365-2265.2003.01770.x","volume":"58","author":"SM Corsello","year":"2003","unstructured":"Corsello SM, Ubertini G, Altomare M, Lovicu RM, Migneco MG, Rota CA, Colosimo C (2003) Giant prolactinomas in men: efficacy of Cabergoline treatment. Clin Endocrinol 58:662\u2013670. https:\/\/doi.org\/10.1046\/j.1365-2265.2003.01770.x","journal-title":"Clin Endocrinol"},{"issue":"10","key":"3722_CR12","first-page":"14","volume":"2","author":"H Irfan","year":"2022","unstructured":"Irfan H, Shafiq W, Siddiqi AI, Ashfaq S, Attaullah S, Munir Alvi A, Khan SA, Abu Bakar M, Azmat U (2022) Prolactinoma: clinical characteristics, management and outcome. Cureus 2(10):14. https:\/\/doi.org\/10.7759\/cureus.29822","journal-title":"Cureus"},{"key":"3722_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0090-3019(82)90020-9","volume":"18","author":"F Afshar","year":"1982","unstructured":"Afshar F, Thomas A (1982) Bromocriptine-induced cerebrospinal fluid rhinorrhea. Surg Neurol 18:61\u201363. https:\/\/doi: 10.1016\/0090-3019(82)90020-9","journal-title":"Surg Neurol"},{"issue":"6","key":"3722_CR14","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1055\/s-0039-1677686","volume":"80","author":"A Arimappamagan","year":"2019","unstructured":"Arimappamagan A, Sadashiva N, Kandregula S, Shukla D, Somanna S (2019) CSF rhinorrhea following medical treatment for prolactinoma: management and challenges. J Neurol Surg B Skull Base 80(6):620\u2013625. https:\/\/doi.org\/10.1055\/s-0039-1677686","journal-title":"J Neurol Surg B Skull Base"},{"key":"3722_CR15","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/0090-3019(94)90013-2","volume":"41","author":"O Barlas","year":"1994","unstructured":"Barlas O, Bayindir C, Hepg\u00fcl K, Can M, Kiris T, Sencer E, \u00dcnal F, Aral F (1994) Bromocriptine-induced cerebrospinal fluid fistula in patients with macroprolactinomas: report of three cases and a review of the literature. Surg Neurol 41:486\u2013489. https:\/\/doi.org\/10.1016\/0090-3019(94)90013-2","journal-title":"Surg Neurol"},{"key":"3722_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/BF03343840","volume":"24","author":"P Cappabianca","year":"2001","unstructured":"Cappabianca P, Lodrini S, Felisati G, Peca C, Cozzi R, Di Sarno A, Cavallo LM, Giombini S, Colao A (2001) Cabergoline-induced CSF rhinorrhea in patients with macroprolactinoma. Report of three cases. J Endocrinol Invest 24:183\u2013187. https:\/\/doi.org\/10.1007\/BF03343840","journal-title":"J Endocrinol Invest"},{"issue":"6","key":"3722_CR17","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s11102-018-0907-1","volume":"21","author":"T \u010ces\u00e1k","year":"2018","unstructured":"\u010ces\u00e1k T, Poczos P, Adamkov J, N\u00e1hlovsk\u00fd J, Ka\u0161parov\u00e1 P, Gabalec F, \u010celakovsk\u00fd P, Choutka O (2018) Medically induced CSF rhinorrhea following treatment of macroprolactinoma: case series and literature review. Pituitary 21(6):561\u2013570. https:\/\/doi.org\/10.1007\/s11102-018-0907-1","journal-title":"Pituitary"},{"key":"3722_CR18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.surneu.2009.06.005","volume":"72","author":"P De Lacy","year":"2009","unstructured":"De Lacy P, Benjamin S, Dixon R, Stephens JW, Redfern R, Price DE (2009) Is surgical intervention frequently required for medically managed macroprolactinomas? A study of spontaneous cerebrospinal fluid rhinorrhea. Surg Neurol 72:461\u2013463. https:\/\/doi.org\/10.1016\/j.surneu.2009.06.005","journal-title":"Surg Neurol"},{"key":"3722_CR19","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/BF01456167","volume":"96","author":"G Hildebrandt","year":"1989","unstructured":"Hildebrandt G, Zierski J, Christophis P, Laun A, Schatz H, Lancranjan I, Klug N (1989) Rhinorrhea following dopamine agonist therapy of invasive macroprolactinoma. Acta Neurochir (Wien) 96:107\u2013113. https:\/\/doi.org\/10.1007\/BF01456167","journal-title":"Acta Neurochir (Wien)"},{"key":"3722_CR20","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1046\/j.1365-2265.2000.00901.x","volume":"52","author":"KS Leong","year":"2000","unstructured":"Leong KS, Foy PM, Swift AC, Atkin SL, Hadden DR, MacFarlane IA (2000) CSF rhinorrhoea following treatment with dopamine agonists for massive invasive prolactinomas. Clin Endocrinol 52:43\u201349. https:\/\/doi.org\/10.1046\/j.1365-2265.2000.00901.x","journal-title":"Clin Endocrinol"},{"key":"3722_CR21","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jocn.2004.03.002","volume":"11","author":"N Nadesapillai","year":"2004","unstructured":"Nadesapillai N, Balcere I, Kaye AH, Tress BM, Colman PG (2004) Acute complications of dopamine agonist treatment for macroprolactinoma\u2013 how uncommon? J Clin Neurosci 11:825\u2013828. https:\/\/doi.org\/10.1016\/j.jocn.2004.03.002","journal-title":"J Clin Neurosci"},{"key":"3722_CR22","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1007\/BF03349214","volume":"29","author":"RT Netea-Maier","year":"2006","unstructured":"Netea-Maier RT, van Lindert EJ, Timmers H, Schakenraad EL, Grotenhuis JA, Hermus AR (2006) Cerebrospinal fluid leakage as complication of treatment with Cabergoline for macroprolactinomas. J Endocrinol Invest 29:1001\u20131005. https:\/\/doi.org\/10.1007\/BF03349214","journal-title":"J Endocrinol Invest"},{"key":"3722_CR23","first-page":"140020","volume":"2014","author":"JK Prague","year":"2014","unstructured":"Prague JK, Ward CL, Mustafa OG, Whitelaw BC, King A, Thomas NW, Gilbert J (2014) Delayed presentation of late-onset cerebrospinal fluid rhinorrhea following dopamine agonist therapy for giant prolactinoma. Endocrinol Diabetes Metab Case Rep 2014:140020. https:\/\/doi: 10.1530\/EDM-14-0020","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"3722_CR24","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1210\/jc.2007-0373","volume":"92","author":"SGI Suliman","year":"2007","unstructured":"Suliman SGI, Gurlek A, Byrne JV, Sullivan N, Thanabalasingham G, Cudlip S, Ansorge O, Wass JAH (2007) Nonsurgical cerebrospinal fluid rhinorrhea in invasive macroprolactinoma: incidence, radiological, and clinicopathological features. J Clin Endocrinol Metab 92:3829\u20133835. https:\/\/doi: 10.1210\/jc.2007-0373","journal-title":"J Clin Endocrinol Metab"},{"key":"3722_CR25","doi-asserted-by":"publisher","unstructured":"Wu ZR, Zhang Y, Cai L, Lin SJ, Su ZP, Wei YX, Shang HB, Yang WL, Zhao WG, Wu ZB (2016) Long-term clinical outcomes of invasive giant prolactinomas after a mean ten-year followup. Int J Endocrinol 2016: 8580750. https:\/\/doi.org\/10.1155\/2016\/8580750","DOI":"10.1155\/2016\/8580750"},{"key":"3722_CR26","doi-asserted-by":"publisher","unstructured":"Kim HK, Hong JW, Moon JH, Ahn SS, Kim EH, Lee SK, Lee EJ, Park YW, Ku CR (2021) Efficacy and cerebrospinal fluid rhinorrhea after cabergoline treatment in patients with bioactive macroprolactinoma. Cancers (Basel) 26;13(21): 5374. https:\/\/doi.org\/10.3390\/cancers13215374","DOI":"10.3390\/cancers13215374"},{"issue":"5","key":"3722_CR27","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1080\/02688697.2021.1903389","volume":"37","author":"CK Milton","year":"2021","unstructured":"Milton CK, Lee BJ, Voronovich ZA, Conner AK, McKinney KA, El Rassi ET, Lim J, Glenn CA (2021) Prolactinoma extension as a contributing factor in dopamine agonist-induced CSF rhinorrhea: a systematic review of the literature. Br J Neurosurg 37(5):976\u2013981. https:\/\/doi: 10.1080\/02688697.2021","journal-title":"Br J Neurosurg"},{"issue":"6","key":"3722_CR28","doi-asserted-by":"publisher","first-page":"E2","DOI":"10.3171\/2012.4.FOCUS1268","volume":"32","author":"G Lam","year":"2012","unstructured":"Lam G, Mehta V, Zada G (2012) Spontaneous and medically induced cerebrospinal fluid leakage in the setting of pituitary adenomas: review of the literature. Neurosurg Focus 32(6):E2. https:\/\/doi.org\/10.3171\/2012.4.FOCUS1268","journal-title":"Neurosurg Focus"},{"key":"3722_CR29","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/jemt.1070200205","volume":"20","author":"W Saeger","year":"1992","unstructured":"Saeger W (1992) Effect of drugs on pituitary ultrastructure. Microsc Res Tech 20:162\u2013176. https.\/\/","journal-title":"Microsc Res Tech"},{"key":"3722_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/BF00588432","volume":"34","author":"P Lundin","year":"1992","unstructured":"Lundin P, Nyman R, Burman P, Lundberg PO, Muhr C (1992) MRI of pituitary macroadenomas with reference to hormonal activity. Neuroradiology 34:43\u201351. https:\/\/doi.org\/10.1007\/BF00588432","journal-title":"Neuroradiology"},{"key":"3722_CR31","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3171\/jns.1986.64.3.0402","volume":"64","author":"WR Selman","year":"1986","unstructured":"Selman WR, Laws ER Jr, Scheithauer BW, Carpenter SM (1986) The occurrence of dural invasion in pituitary adenomas. J Neurosurg 64:402\u2013407. https:\/\/doi.org\/10.3171\/jns.1986.64.3.0402","journal-title":"J Neurosurg"},{"key":"3722_CR32","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3171\/jns.1986.65.6.0733","volume":"65","author":"BW Scheithauer","year":"1986","unstructured":"Scheithauer BW, Kovacs KT, Laws ER Jr, Randall RV (1986) Pathology of invasive pituitary tumors with special reference to functional classification. J Neurosurg 65:733\u2013744. https:\/\/doi.org\/10.3171\/jns.1986.65.6.0733","journal-title":"J Neurosurg"},{"issue":"4","key":"3722_CR33","doi-asserted-by":"publisher","first-page":"E4","DOI":"10.3171\/2010.7.FOCUS10155","volume":"29","author":"G Zada","year":"2010","unstructured":"Zada G, Lin N, Laws ER Jr (2010) Patterns of extrasellar extensions in growth hormone-secreting and non-functional pituitary macroadenomas. Neurosurg Focus 29(4):E4. https:\/\/doi.org\/10.3171\/2010.7.FOCUS10155","journal-title":"Neurosurg Focus"},{"issue":"3","key":"3722_CR34","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1227\/00006123-198209000-00010","volume":"11","author":"AM Landolt","year":"1982","unstructured":"Landolt AM (1982) Cerebrospinal fluid rhinorrhea: a complication of therapy for invasive prolactinomas. Neurosurgery 11(3):395\u2013401. https:\/\/doi.org\/10.1227\/00006123-198209000-00010","journal-title":"Neurosurgery"},{"issue":"4","key":"3722_CR35","first-page":"302","volume":"44","author":"A Tamasauskas","year":"2008","unstructured":"Tamasauskas A, Sink\u016bnas K, Draf W, Deltuva V, Matukevicius A, Rastenyte D, Vaitkus S (2008) Management of cerebrospinal fluid leak after surgical removal of pituitary adenomas. Med (Kaunas) 44(4):302\u2013307.https:\/\/doi.org\/PMID:18469507","journal-title":"Med (Kaunas)"},{"issue":"2","key":"3722_CR36","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s11102-010-0274-z","volume":"14","author":"B Thakur","year":"2011","unstructured":"Thakur B, Jesurasa AR, Ross R, Carroll TA, Mirza S, Sinha S (2011) Transnasal trans-sphenoidal endoscopic repair of CSF leak secondary to invasive pituitary tumours using a nasoseptal flap. Pituitary 14(2):163\u2013167. https:\/\/doi.org\/10.1007\/s11102-010-0274-z","journal-title":"Pituitary"},{"key":"3722_CR37","doi-asserted-by":"publisher","first-page":"e629","DOI":"10.1016\/j.wneu.2019.12.100","volume":"135","author":"B Liu","year":"2020","unstructured":"Liu B, Wang Y, Zheng T, Liu S, Lv W, Lu D, Chen L, Chen L, Ma T, Gao G, Qu Y, He S (2020) Effect of intraoperative lumbar drainage on gross total resection and cerebrospinal fluid leak rates in endoscopic transsphenoidal surgery of pituitary macroadenomas. World Neurosurg 135:e629\u2013e639. https:\/\/doi.org\/10.1016\/j.wneu.2019.12.100","journal-title":"World Neurosurg"},{"key":"3722_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2018.4.JNS172447","volume":"1","author":"NT Zwagerman","year":"2018","unstructured":"Zwagerman NT, Wang EW, Shin SS, Chang YF, Fernandez-Miranda JC, Snyderman CH, Gardner PA (2018) Does lumbar drainage reduce postoperative cerebrospinal fluid leakafter endoscopic endonasal skull base surgery? A prospective, randomized controlled trial. J Neurosurg 1:1\u20137. https:\/\/doi.org\/10.3171\/2018.4.JNS172447","journal-title":"J Neurosurg"},{"key":"3722_CR39","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.wneu.2020.08.129","volume":"144","author":"D Abe","year":"2020","unstructured":"Abe D, Ogiwara T, Nakamura T, Ichinose S, Fujii Y, Hanaoka Y, Ito K, Horiuchi T (2020) Treatment strategy for giant invasive macroprolactinoma with spontaneous cerebrospinal fluid rhinorrhea: A case report and literature review. World Neurosurg 144:19\u201323. https:\/\/doi.org\/10.1016\/j.wneu.2020.08.129","journal-title":"World Neurosurg"},{"key":"3722_CR40","doi-asserted-by":"publisher","unstructured":"Kalinin PL, Shkarubo AN, Astafieva LI, Chernov IV, Ismailov DB, Kadashev BA, Fomichev DV, Kutin MA, Sharipov OI, Andreev DN, Fomochkina LA (2017) Nazal\u2019naia likvoreia pri pervichnom lechenii bol\u2019shikh i gigantskikh prolaktinom agonistami dofamina [Cerebrospinal fluid rhinorrhea in primary treatment of large and giant prolactinomas with dopamine agonists]. Zh Vopr Neirokhir Im N N Burdenko. 81 (6): 32\u201339. Russian. https:\/\/doi.org\/10.17116\/neiro201781632-39","DOI":"10.17116\/neiro201781632-39"},{"issue":"1","key":"3722_CR41","doi-asserted-by":"publisher","first-page":"65","DOI":"10.4183\/aeb.2024.65","volume":"20","author":"DI Rotariu","year":"2024","unstructured":"Rotariu DI, Costachescu B, Ungureanu MC, Eva L, Leustean L, Preda C, Cristea C, Iliescu BF (2024) The place of surgery in the management of prolactin secreting adenomas. Acta Endocrinol (Buchar) 20(1):65\u201373. https:\/\/doi: 10.4183\/aeb.2024.65","journal-title":"Acta Endocrinol (Buchar)"},{"key":"3722_CR42","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1385\/ENDO:14:3:329","volume":"14","author":"L Stefaneanu","year":"2001","unstructured":"Stefaneanu L, Kovacs K, Horvage E, Buchfelder M, Fahlbusch R, Lancraigan I (2001) Dopamine D2 receptor gene expression in human adenohypophyseal adenomas. Endocrine 14:329\u2013336. https:\/\/doi: 10.1007\/BF01605931","journal-title":"Endocrine"},{"key":"3722_CR43","doi-asserted-by":"publisher","first-page":"04","DOI":"10.4103\/0974-1208.86096","volume":"4","author":"P Singh","year":"2011","unstructured":"Singh P, Singh M, Cugati G, Singh AK (2011) Bromocriptine or cabergoline-induced cerebrospinal fluid rhinorrhea: A life-threating complication during management of prolactinoma. J Hum Reprod Sci 4:04\u2013105. https:\/\/doi.org\/10.4103\/0974-1208.86096","journal-title":"J Hum Reprod Sci"},{"key":"3722_CR44","doi-asserted-by":"crossref","unstructured":"Mankia SK, Weerakkody RA, Wijesuriya S, Kandasamy N, Finucane F, Guilfoyle M, Antoun N, Pickard J, Gurnell M (2009) Spontaneous cerebrospinal fluid rhinorrhoea as the presenting feature of an invasive macroprolactinoma. BMJ Case Rep Bcr. 12.2008.1383. https:\/\/doi: 10.1136\/bcr.12.2008.1383","DOI":"10.1136\/bcr.12.2008.1383"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-025-03722-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00423-025-03722-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-025-03722-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T06:11:12Z","timestamp":1746511872000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00423-025-03722-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,6]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3722"],"URL":"https:\/\/doi.org\/10.1007\/s00423-025-03722-8","relation":{},"ISSN":["1435-2451"],"issn-type":[{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,6]]},"assertion":[{"value":"5 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent has been obtained from all individual participants included in this retrospective study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors affirm that human research participant provided informed consent for publication of the figures.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"151"}}